Your browser doesn't support javascript.
loading
Prospective evaluation of patient-reported outcomes of invisible ink tattoos for the delivery of external beam radiation therapy: the PREFER trial.
Hardy-Abeloos, Camille; Gorovets, Daniel; Lewis, Aurora; Ji, Wenyan; Lozano, Alicia; Tung, Chih Chun; Yu, Francis; Hanlon, Alexandra; Lin, Haibo; Kha, Anh; Yamada, Yoshiya; Kabarriti, Rafi; Lazarev, Stanislav; Hasan, Shaakir; Chhabra, Arpit M; Simone, Charles B; Choi, J Isabelle.
Afiliación
  • Hardy-Abeloos C; Department of Radiation Oncology, NYU School of Medicine, New York, NY, United States.
  • Gorovets D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Lewis A; New York Proton Center, New York, NY, United States.
  • Ji W; New York Proton Center, New York, NY, United States.
  • Lozano A; Rutgers Robert Wood Johnson Medical School, Newark, NJ, United States.
  • Tung CC; Center for Biostatistics and Health Data Science, Department of Statistics, Virginia Tech, Roanoke, VA, United States.
  • Yu F; Center for Biostatistics and Health Data Science, Department of Statistics, Virginia Tech, Roanoke, VA, United States.
  • Hanlon A; New York Proton Center, New York, NY, United States.
  • Lin H; New York Proton Center, New York, NY, United States.
  • Kha A; Center for Biostatistics and Health Data Science, Department of Statistics, Virginia Tech, Roanoke, VA, United States.
  • Yamada Y; New York Proton Center, New York, NY, United States.
  • Kabarriti R; New York Proton Center, New York, NY, United States.
  • Lazarev S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Hasan S; New York Proton Center, New York, NY, United States.
  • Chhabra AM; New York Proton Center, New York, NY, United States.
  • Simone CB; Department of Radiation Oncology, Montefiore Medical Center, Bronx, NY, United States.
  • Choi JI; New York Proton Center, New York, NY, United States.
Front Oncol ; 14: 1374258, 2024.
Article en En | MEDLINE | ID: mdl-38590650
ABSTRACT

Introduction:

Invisible ink tattoos (IITs) avoid cosmetic permanence of visible ink tattoos (VITs) while serving as more reliable landmarks for radiation setup than tattooless setups. This trial evaluated patient-reported preference and feasibility of IIT implementation. Methods and materials In an IRB-approved, single institution, prospective trial, patients receiving proton therapy underwent IIT-based treatment setup. A survey tool assessed patient preference on tattoos using a Likert scale. Matched patients treated using our institutional standard tattooless setup were identified; treatment times and image guidance requirements were evaluated between tattooless and IIT-based alignment approaches. Distribution differences were estimated using Wilcoxon rank-sum tests or Chi-square tests.

Results:

Of 94 eligible patients enrolled, median age was 58 years, and 58.5% were female. Most common treatment sites were breast (18.1%), lung (17.0%) and pelvic (14.9%). Patients preferred to receive IITs versus VITs (79.8% pre-treatment and 75.5% post-treatment, respectively). Patients were willing to travel farther from home to avoid VITs versus IITs (p<0.01). Females were willing to travel (45.5% vs. 23.1%; p=0.04) and pay additional money to avoid VITs (34.5% vs. 5.1%; p<0.01). Per-fraction average +treatment time and time from on table/in room to first beam were shorter with IIT-based vs. tattooless setup (12.3min vs. 14.1min; p=0.04 and 24.1min vs. 26.2min; p=0.02, respectively).

Discussion:

In the largest prospective trial on IIT-based radiotherapy setup to date, we found that patients prefer IITs to VITs. Additionally, IIT-based alignment is an effective and efficient strategy in comparison with tattooless setup. Standard incorporation of IITs for patient setup should be strongly considered.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza